RNAseq data from general (i.e. not EOPC) primary prostate adenocarcinomas available in The Cancer Genome Atlas (TCGA) [27] show that high ESRP1 (but not ESRP2) gene expression levels correlate with poorer patient prognosis [28–30]. Here, ESRP1 is linked to prostate adenocarcinoma.